Supreme Court Faces Choice on Pay-for-Delay Cases

Generic Line
The FTC Thursday asked the Supreme Court to take up and overturn an 11th Circuit Court’s decision that upheld the legality of reverse patent settlements between branded drug makers and generic competitors.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00